| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 901 | 2017 |
| Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users L Baandrup, BH Ebdrup, JØ Rasmussen, J Lindschou, C Gluud, ... Cochrane Database of Systematic Reviews, 2018 | 149 | 2018 |
| Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia BH Ebdrup, B Glenthøj, H Rasmussen, B Aggernaes, AR Langkilde, ... Journal of Psychiatry and Neuroscience 35 (2), 95-104, 2010 | 142 | 2010 |
| Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia H Rasmussen, D Erritzoe, R Andersen, BH Ebdrup, B Aggernaes, ... Archives of General Psychiatry 67 (1), 9-16, 2010 | 129 | 2010 |
| Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis D Siskind, M Hahn, CU Correll, A Fink‐Jensen, AW Russell, N Bak, ... Diabetes, Obesity and Metabolism 21 (2), 293-302, 2019 | 99 | 2019 |
| Serotonin 2A receptor antagonists for treatment of schizophrenia BH Ebdrup, H Rasmussen, J Arnt, B Glenthøj Expert opinion on investigational drugs 20 (9), 1211-1223, 2011 | 93 | 2011 |
| Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms BH Ebdrup, A Skimminge, H Rasmussen, B Aggernaes, B Oranje, ... International Journal of Neuropsychopharmacology 14 (1), 69-82, 2011 | 91 | 2011 |
| Association of structural magnetic resonance imaging measures with psychosis onset in individuals at clinical high risk for developing psychosis: an ENIGMA working group mega … M Jalbrzikowski, RA Hayes, SJ Wood, D Nordholm, JH Zhou, P Fusar-Poli, ... JAMA psychiatry 78 (7), 753-766, 2021 | 80 | 2021 |
| Striatal reward activity and antipsychotic-associated weight change in patients with schizophrenia undergoing initial treatment MØ Nielsen, E Rostrup, S Wulff, B Glenthøj, BH Ebdrup JAMA psychiatry 73 (2), 121-128, 2016 | 79 | 2016 |
| Adverse cardiac events in out‐patients initiating clozapine treatment: a nationwide register‐based study C Rohde, C Polcwiartek, K Kragholm, BH Ebdrup, D Siskind, J Nielsen Acta Psychiatrica Scandinavica 137 (1), 47-53, 2018 | 73 | 2018 |
| Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review BH Ebdrup, H Nørbak, S Borgwardt, B Glenthøj Curr Med Chem 20 (3), 438-47; DOI: 10.2174/0929867311320030015, 2013 | 69 | 2013 |
| Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months’ treatment with quetiapine B Aggernaes, BY Glenthoj, BH Ebdrup, H Rasmussen, H Lublin, B Oranje International Journal of Neuropsychopharmacology 13 (10), 1383-1395, 2010 | 69 | 2010 |
| Effect of GLP‐1 Receptor Agonist Treatment on Body weight in Obese Antipsychotic‐treated Patients with Schizophrenia: a Randomized, Placebo‐controlled Trial PL Ishøy, FK Knop, BV Broberg, N Bak, UB Andersen, NR Jørgensen, ... Diabetes, Obesity and Metabolism, 2016 | 66 | 2016 |
| Haloperidol for the treatment of delirium in ICU patients NC Andersen-Ranberg, LM Poulsen, A Perner, J Wetterslev, S Estrup, ... New England Journal of Medicine 387 (26), 2425-2435, 2022 | 61 | 2022 |
| The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients R Andersen, B Fagerlund, H Rasmussen, BH Ebdrup, B Aggernaes, ... European Psychiatry 28 (6), 332-339, 2013 | 59 | 2013 |
| Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis KB Bojesen, BH Ebdrup, K Jessen, A Sigvard, K Tangmose, RAE Edden, ... Psychological medicine 50 (13), 2182-2193, 2020 | 58 | 2020 |
| P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment B Oranje, B Aggernaes, H Rasmussen, BH Ebdrup, BY Glenthøj Schizophrenia bulletin 39 (2), 472-480, 2013 | 57 | 2013 |
| Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade BH Ebdrup, JM Raghava, MØ Nielsen, E Rostrup, B Glenthøj Journal of Psychiatry and Neuroscience 41 (2), 133-141, 2016 | 54 | 2016 |
| Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia W Marteene, K Winckel, S Hollingworth, S Kisely, E Gallagher, M Hahn, ... Expert Opinion on Drug Safety 18 (12), 1149-1160, 2019 | 50 | 2019 |
| Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine H Rasmussen, BH Ebdrup, D Erritzoe, B Aggernaes, B Oranje, J Kalbitzer, ... Psychopharmacology 213, 583-592, 2011 | 50 | 2011 |
Egill RostrupCentre for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, Denmark在 dadlnet.dk 的電子郵件地址已通過驗證
